Home

Hochschule Unglücklicherweise Teilt abatacept diabetes Weihrauch Aufregung Ungeschickt

Typ 1 Diabetes im Vorstadium stoppen? ABATACEPT-Studie
Typ 1 Diabetes im Vorstadium stoppen? ABATACEPT-Studie

Drug Insight: abatacept for the treatment of rheumatoid arthritis | Nature  Reviews Rheumatology
Drug Insight: abatacept for the treatment of rheumatoid arthritis | Nature Reviews Rheumatology

Arthritis drug abatacept slows type 1 diabetes progression - Diabetes
Arthritis drug abatacept slows type 1 diabetes progression - Diabetes

Diabetes Mellitus Typ 1: Durch Immunmodulation verhindern?
Diabetes Mellitus Typ 1: Durch Immunmodulation verhindern?

Aktuell Lesenswertes - Deutsche Autoimmun-Stiftung
Aktuell Lesenswertes - Deutsche Autoimmun-Stiftung

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
Uncovering Pathways to Personalized Therapies in Type 1 Diabetes

CTLA4-Ig (abatacept): a promising investigational drug for use in type 1  diabetes
CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes

Artikel Deutsches Ärzteblatt
Artikel Deutsches Ärzteblatt

JCI Insight - B lymphocyte alterations accompany abatacept resistance in  new-onset type 1 diabetes
JCI Insight - B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes

Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to  ameliorate proteinuric kidney disease | American Journal of  Physiology-Renal Physiology
Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease | American Journal of Physiology-Renal Physiology

Co-stimulation modulation with abatacept in patients with recent-onset type  1 diabetes: a randomised, double-blind, placebo-controlled trial - The  Lancet
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial - The Lancet

Follicular helper T cell profiles predict response to costimulation  blockade in type 1 diabetes | Nature Immunology
Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes | Nature Immunology

Typ 1 Diabetes im Vorstadium stoppen? ABATACEPT-Studie
Typ 1 Diabetes im Vorstadium stoppen? ABATACEPT-Studie

New Frontiers in the Treatment of Type 1 Diabetes - ScienceDirect
New Frontiers in the Treatment of Type 1 Diabetes - ScienceDirect

Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based  Treatment Strategy for Autoimmune Type 1 Diabetes
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes

Abatacept decreases TFH cells during an ongoing autoimmune response in... |  Download Scientific Diagram
Abatacept decreases TFH cells during an ongoing autoimmune response in... | Download Scientific Diagram

Fighting the uphill battle to cure type 1 diabetes - Lee - 2021 - Journal  of Diabetes Investigation - Wiley Online Library
Fighting the uphill battle to cure type 1 diabetes - Lee - 2021 - Journal of Diabetes Investigation - Wiley Online Library

News
News

Abatacept Lowers Diabetes Risk in RA
Abatacept Lowers Diabetes Risk in RA

ORENCIA® (abatacept) | Official Patient Website
ORENCIA® (abatacept) | Official Patient Website

Erhöhtes Diabetesrisiko bei Patienten mit rheumatoider Arthritis
Erhöhtes Diabetesrisiko bei Patienten mit rheumatoider Arthritis

JCI Insight - B lymphocyte alterations accompany abatacept resistance in  new-onset type 1 diabetes
JCI Insight - B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes

Growing up with TrialNet — Screened as children and now in their 20s, two  Abatacept Prevention Study participants share their stories | TRIALNET Type  1 Diabetes TrialNet
Growing up with TrialNet — Screened as children and now in their 20s, two Abatacept Prevention Study participants share their stories | TRIALNET Type 1 Diabetes TrialNet

A machine learning approach to predict response to immunotherapy in type 1  diabetes | Cellular & Molecular Immunology
A machine learning approach to predict response to immunotherapy in type 1 diabetes | Cellular & Molecular Immunology

Co-stimulation modulation with abatacept in patients with recent-onset type  1 diabetes: a randomised, double-blind, placebo-controlled trial - The  Lancet
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial - The Lancet